Psychosocial and Clinical Factors Associated with Family Communication of Cancer Genetic Test Results among Women Diagnosed with Breast Cancer at a Young Age
- PMID: 27422778
- PMCID: PMC5239754
- DOI: 10.1007/s10897-016-9995-0
Psychosocial and Clinical Factors Associated with Family Communication of Cancer Genetic Test Results among Women Diagnosed with Breast Cancer at a Young Age
Abstract
Genetic test results have medical implications beyond the patient that extend to biological family members. We examined psychosocial and clinical factors associated with communication of genetic test results within families. Women (N = 1080) diagnosed with breast cancer at age 40 or younger completed an online survey; 920 women that reported prior cancer genetic testing were included in analysis. We examined the proportion of immediate family members to whom they communicated genetic test results, and built multivariable regression models to examine clinical and psychosocial variables associated with the proportion score. Participants were most likely to communicate test results to their mother (83 %) and least likely to their son (45 %). Participants who carried a BRCA mutation (OR = 1.34; 95 % CI = 1.06, 1.70), had higher interest in genomic information (OR = 1.55; 95 % CI = 1.26, 1.91) and lower genetic worry (OR = 0.91; 95 % CI = 0.86, 0.96) communicated genetic test results to a greater proportion of their immediate family members. Participants with a BRCA1/2 mutation shared their genetic test results with more male family members (OR = 1.72; 95 % CI = 1.02, 2.89). Our findings suggest that patients with high worry about genetic risks, low interest in genomic information, or receive a negative genetic test result will likely need additional support to encourage family communication.
Keywords: BRCA 1/2; Breast cancer; Family communication; Genetics.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Similar articles
-
Prophylactic mastectomy for the prevention of breast cancer.Cochrane Database Syst Rev. 2004 Oct 18;(4):CD002748. doi: 10.1002/14651858.CD002748.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2010 Nov 10;(11):CD002748. doi: 10.1002/14651858.CD002748.pub3. PMID: 15495033 Updated.
-
Risk-reducing mastectomy for the prevention of primary breast cancer.Cochrane Database Syst Rev. 2018 Apr 5;4(4):CD002748. doi: 10.1002/14651858.CD002748.pub4. Cochrane Database Syst Rev. 2018. PMID: 29620792 Free PMC article.
-
Examining BRCA Previvors' Social Media Content Creation as a Form of Self and Community Care: Qualitative Interview Study.J Med Internet Res. 2025 Mar 3;27:e67794. doi: 10.2196/67794. J Med Internet Res. 2025. PMID: 40053732 Free PMC article.
-
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012464. doi: 10.1002/14651858.CD012464.pub2. Cochrane Database Syst Rev. 2018. PMID: 30141832 Free PMC article.
-
Improved health perception after genetic counselling for women at high risk of breast and/or ovarian cancer: construction of new questionnaires--an Italian exploratory study.J Cancer Res Clin Oncol. 2016 Mar;142(3):633-48. doi: 10.1007/s00432-015-2062-7. Epub 2015 Nov 17. J Cancer Res Clin Oncol. 2016. PMID: 26577826 Free PMC article.
Cited by
-
"It would be so much easier": health system-led genetic risk notification-feasibility and acceptability of cascade screening in an integrated system.J Community Genet. 2019 Oct;10(4):461-470. doi: 10.1007/s12687-019-00412-z. Epub 2019 Mar 6. J Community Genet. 2019. PMID: 30843145 Free PMC article.
-
Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.JCO Precis Oncol. 2018;2018:PO.18.00060. doi: 10.1200/PO.18.00060. Epub 2018 Aug 16. JCO Precis Oncol. 2018. PMID: 30761386 Free PMC article.
-
Sharing genetic test results of germline pathogenic variants of hereditary cancer with relatives: A single-center cross-sectional study.Jpn J Clin Oncol. 2021 Oct 5;51(10):1547-1553. doi: 10.1093/jjco/hyab110. Jpn J Clin Oncol. 2021. PMID: 34244736 Free PMC article.
-
Expanding the search for germline pathogenic variants for breast cancer. How far should we go and how high should we jump? The missed opportunity!Oncol Rev. 2021 Jun 24;15(1):544. doi: 10.4081/oncol.2021.544. eCollection 2021 Feb 26. Oncol Rev. 2021. PMID: 34267891 Free PMC article.
-
Sharing genetic test results with family members of BRCA, PALB2, CHEK2, and ATM carriers.Patient Educ Couns. 2021 Apr;104(4):720-725. doi: 10.1016/j.pec.2020.12.019. Epub 2021 Jan 5. Patient Educ Couns. 2021. PMID: 33455826 Free PMC article.
References
-
- Cameron LD, Reeve J. Risk perceptions, worry, and attitudes about genetic testing for breast cancer susceptibility. Psychology & Health. 2006;21(2):211–230. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous